About Clover Health: Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare.

FRANKLIN, Tenn., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today ...

Clover Health Medicare Advantage plans are available in five states and get average star ratings from CMS. Many, or all, of the products featured on this page are from our advertising partners who ...

Analyst Richard Close from Canaccord Genuity maintained a Buy rating on Clover Health Investments (CLOV – Research Report) and keeping the price target at $3.20. Richard Close has given his Buy ...

Clover Health Investments shares are trading higher by 4.6% Friday afternoon. The company announced that CMS raised its PPO Medicare Advantage plans' Star rating to 4 Stars for 2025. What To Know ...

On Friday, Clover Health Investments Corp (CLOV) stock saw a modest uptick, ending the day at $3.92 which represents a slight increase of $0.13 or 3.43% from the prior close of $3.79. The stock opened ...

David Tsay, M.D., was appointed chief medical officer of Counterpart Health, a Clover Health subsidiary, this month. Counterpart Health is Clover’s AI assistant tool for physicians. It is sold ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

FRANKLIN, Tenn., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover,” "Clover Health” or the "Company”), today announced its participation in the following ...